Grail shareholders face $51.32-per-share loss claim as Levi & Korsinsky targets NHS-Galleri confidence collapse
Confidence in early-detection diagnostics can reverse sharply, and one such reversal has now drawn formal legal action. Grail, Inc. (NASDAQ: GRAL) is at the center of a securities class action